These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 27908539

  • 1. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA, Abuo-Rahma GE, Abdelhafez EM, Hassan HA, Abd El-Baky RM.
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM, Ali MA, Abuo-Rahma GEAA, AbdelAziz N.
    Adv Exp Med Biol; 2017 Feb; 973():99-113. PubMed ID: 28190143
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives.
    Abdel-Aal MAA, Shaykoon MSA, Abuo-Rahma GEAA, Mohamed MFA, Badr M, Abdel-Aziz SA.
    Pharmacol Rep; 2021 Jun; 73(3):891-906. PubMed ID: 33389728
    [Abstract] [Full Text] [Related]

  • 4. The effect of antibiotics and acetohydroxamic acid on bacterial hydrolysis of urea.
    Vince AJ, Chadwick VS.
    J Antimicrob Chemother; 1978 Mar; 4(2):189-91. PubMed ID: 348668
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of urease activity by dipeptidyl hydroxamic acids.
    Odake S, Nakahashi K, Morikawa T, Takebe S, Kobashi K.
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2764-8. PubMed ID: 1464106
    [Abstract] [Full Text] [Related]

  • 6. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I, Hamilton-Miller JM, Brumfitt W.
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [Abstract] [Full Text] [Related]

  • 7. 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.
    Shi WK, Deng RC, Wang PF, Yue QQ, Liu Q, Ding KL, Yang MH, Zhang HY, Gong SH, Deng M, Liu WR, Feng QJ, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2016 Oct 01; 24(19):4519-4527. PubMed ID: 27492194
    [Abstract] [Full Text] [Related]

  • 8. In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.
    Arora R, Issar U, Kakkar R.
    J Mol Graph Model; 2018 Aug 01; 83():64-73. PubMed ID: 29775804
    [Abstract] [Full Text] [Related]

  • 9. Discovery of Novel Dihydropyrimidine and hydroxamic acid hybrids as potent Helicobacter pylori Urease inhibitors.
    Mamidala R, Bhimathati SRS, Vema A.
    Bioorg Chem; 2021 Sep 01; 114():105010. PubMed ID: 34102519
    [Abstract] [Full Text] [Related]

  • 10. The influence of acetohydroxamic acid on experimental proteus pyelonephritis.
    Maclaren DM.
    Invest Urol; 1974 Sep 01; 12(2):146-9. PubMed ID: 4605277
    [No Abstract] [Full Text] [Related]

  • 11. Morphological changes in Proteus mirabilis O18 biofilm under the influence of a urease inhibitor and a homoserine lactone derivative.
    Czerwonka G, Arabski M, Wąsik S, Jabłońska-Wawrzycka A, Rogala P, Kaca W.
    Arch Microbiol; 2014 Mar 01; 196(3):169-77. PubMed ID: 24481535
    [Abstract] [Full Text] [Related]

  • 12. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep 01; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A, Rozalski A.
    Microbiol Res; 2014 Sep 01; 169(7-8):579-84. PubMed ID: 24239192
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid.
    Rizzo M, Nicoletti P, Bartoletti R, Luciani E.
    Contrib Nephrol; 1987 Sep 01; 58():219-21. PubMed ID: 3319403
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clodronic Acid has Strong Inhibitory Interactions with the Urease Enzyme of Helicobacter pylori: Computer-aided Design and in vitro Confirmation.
    Fath MK, Khalili S, Boojar MMA, Hashemi ZS, Zarei M.
    Curr Comput Aided Drug Des; 2024 Sep 01; 20(7):1100-1112. PubMed ID: 37957909
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study.
    Abdulwahab HG, Harras MF, El Menofy NG, Hegab AM, Essa BM, Selim AA, Sakr TM, El-Zahabi HSA.
    Bioorg Med Chem; 2020 Dec 01; 28(23):115759. PubMed ID: 32992246
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.